the pool of covid vaccine vaccination efforts and how those are behind. doctor hotez, you ve been working on a vaccine to use technology. to have produced the technology with no intellectual property control. that can be distributed in manufactured across the world. a low cost vaccine that got approval. i believe for use in india. that you ve been working on. can you tell us about that? how important that is? in our texas children senator vaccine development. part of the baylor college of medicine. which i coed with my science partner for the last 20 years. what we do, we developed low cost protein vaccines. that the big pharma companies won t make. because they are four diseases of poverty. ironically, about ten years ago, we adopted a coronavirus vaccine program. that, on top of our parasitic disease program. all we know how to do is make low-cost durable vaccines for use and research. that service well when we made
0 democracy. and the truth about the great shoplifting freak out of 2020. one state now proposing a bounty for parents who find banned books in school. when all in, starts right now. good evening from new york. i m chris hayes. that s we are about to enter a new year. the third calendar year of the pandemic. take a look at this map. put out by the centers of disease control and prevention. it shows the level of community transmission of covid in america right now. laughing at sort of a joke. it s a pretty clear map. solid red in all 50 states. district of columbia and puerto rico experiencing cdc calls high transmission. we are getting new records. as daily case counts sore across the country to the highest amount we diversity. can see on this chart. line is practically going straight up. as we assess where we are right now. i think it s important to understand the fact, omicron variant is just much more transmissible than the previous variants. particularly, the early ones. just a dif
center for vaccine development at baylor college of medicine, we ve been developing low cost protein vaccines, the ones that the big pharma companies are not interested in. and then about a decade ago we began working on coronavirus vaccines, and now we ve been able to pivot that program around to covid-19 and developed a low-cost protein vaccine, same technology as used to make the hepatitis b vaccine which parents have been giving to their kids for the last 40 years, it s microbial fermentation and yeast. we licensed it without a patent, with no strings attached to biological e in india, and they re moving forward hopefully soon to release the vaccine for emergency use with an advanced purchase commitment of 300 million doses from the indian government. we ve also licensed them to indonesia, bangladesh, botswana. so, you know, if all the stars
development at baylor has been working on vaccines for a couple of decades. we started working on coronavirus vaccines ten years ago. and we took this pivot. and all of our vaccines are low cost, protein vaccines that could be made at very low cost. and no limits to the scale that you can produce it at, because it s a technology that is similar to the hepatitis b vaccine. so when i say pivot, our center, which is co-headed by myself and my science partner, mary lynn, we turned around and made a covid vaccine. but then did not get a lot of help, really, from either the federal government. and a lot of international agencies. but countries are so desperate for vaccines, because they knew mrna vaccines weren t coming, as they cannot be scaled. we successfully worked with a company in india, they are
Наш кардиолог посочи всички предимства и недостатъци на 4 ваксини срещу К-19 blitz.bg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from blitz.bg Daily Mail and Mail on Sunday newspapers.